• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

经导管多瓣膜置换术治疗高危感染性心内膜炎患者退行性瓣膜假体衰败

Open Transcatheter Multivalve Replacement in Degenerated Valve Prostheses in High-Risk Patients with Endocarditis.

机构信息

Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Center, University of Duisburg-Essen, Essen, Germany.

Department of Medicine, Faculty of Medicine, Imperial College London, London, UK.

出版信息

Braz J Cardiovasc Surg. 2021 Oct 17;36(5):703-706. doi: 10.21470/1678-9741-2020-0394.

DOI:10.21470/1678-9741-2020-0394
PMID:33577266
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8597607/
Abstract

Multivalve redo procedures carry a high surgical risk. We describe an alternative surgical treatment for patients presenting with severely degenerated aortic and mitral valve prostheses who have to undergo open surgery due to endocarditis. Open transcatheter multivalve implantation is a feasible bailout strategy in high-risk patients to save cross-clamp and procedural times to reduce morbidity and mortality.

摘要

多瓣膜再次手术风险较高。我们描述了一种替代手术治疗方法，适用于因感染性心内膜炎而需行开胸手术的严重退行性主动脉瓣和二尖瓣假体患者。对于高危患者，开放式经导管多瓣膜植入术是一种可行的抢救策略，可以缩短体外循环和手术时间，降低发病率和死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ac/8597607/bd0c698a6e47/rbccv-36-05-0703-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ac/8597607/7525280730ca/rbccv-36-05-0703-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ac/8597607/bd0c698a6e47/rbccv-36-05-0703-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ac/8597607/7525280730ca/rbccv-36-05-0703-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ac/8597607/bd0c698a6e47/rbccv-36-05-0703-g02.jpg

相似文献

1
Open Transcatheter Multivalve Replacement in Degenerated Valve Prostheses in High-Risk Patients with Endocarditis.经导管多瓣膜置换术治疗高危感染性心内膜炎患者退行性瓣膜假体衰败
Braz J Cardiovasc Surg. 2021 Oct 17;36(5):703-706. doi: 10.21470/1678-9741-2020-0394.
2
Transcatheter valve-in-valve implantation for degenerated bioprosthetic aortic and mitral valves.经导管瓣中瓣植入术治疗衰败生物瓣主动脉瓣和二尖瓣病变
Expert Rev Med Devices. 2016 Aug;13(8):749-58. doi: 10.1080/17434440.2016.1207521. Epub 2016 Jul 8.
3
Transcatheter valve-in-valve implantation for degenerated bioprosthetic aortic and mitral valves - an update on indications, techniques, and clinical results.经导管瓣中瓣植入术治疗退行性生物瓣主动脉瓣和二尖瓣 - 适应证、技术及临床结果的更新。
Expert Rev Med Devices. 2021 Jul;18(7):597-608. doi: 10.1080/17434440.2021.1939009. Epub 2021 Jun 15.
4
Double transcatheter valve-in-valve implantation for degenerated aortic and mitral bioprostheses.双导管瓣膜中瓣膜植入术治疗退化性主动脉和二尖瓣生物瓣膜
Rev Port Cir Cardiotorac Vasc. 2013 Jul-Sep;20(3):131-4.
5
Transcatheter Mitral Valve Replacement in Patients With Previous Aortic Valve Replacement.经导管二尖瓣置换术治疗既往主动脉瓣置换术后患者。
Circ Cardiovasc Interv. 2018 Oct;11(10):e006412. doi: 10.1161/CIRCINTERVENTIONS.118.006412.
6
Mitro-aortic valve-in-valve procedures: Many challenges in little space.二尖瓣-主动脉瓣瓣中瓣手术：狭小空间中的诸多挑战。
J Card Surg. 2020 Aug;35(8):2089-2092. doi: 10.1111/jocs.14806. Epub 2020 Jul 11.
7
Series of transcatheter valve-in-valve implantations in high-risk patients with degenerated bioprostheses in aortic and mitral position.经导管主动脉瓣和二尖瓣生物瓣衰败患者高危人群行瓣中瓣植入术系列。
Catheter Cardiovasc Interv. 2010 Oct 1;76(4):608-15. doi: 10.1002/ccd.22618.
8
Valve-in-Valve Implantation Using the ACURATE Neo in Degenerated Aortic Bioprostheses: An International Multicenter Analysis.经瓣中瓣植入术在退行性主动脉生物瓣中的应用：一项国际多中心分析。
JACC Cardiovasc Interv. 2019 Nov 25;12(22):2309-2316. doi: 10.1016/j.jcin.2019.07.042.
9
Simultaneous transcatheter aortic and mitral valve-in-valve implantation in a patient with degenerated bioprostheses and high surgical risk.一名生物假体退化且手术风险高的患者同时行经导管主动脉瓣和二尖瓣瓣中瓣植入术。
Thorac Cardiovasc Surg. 2011 Dec;59(8):490-2. doi: 10.1055/s-0031-1280368. Epub 2011 Nov 11.
10
Simultaneous transcatheter valve-in-valve replacement of severely degenerated bioprosthetic aortic and mitral prostheses.经导管主动脉瓣-二尖瓣瓣中瓣置换术同期治疗严重退行性生物瓣主动脉瓣和二尖瓣置换术后瓣膜衰败。
Clin Res Cardiol. 2022 Dec;111(12):1396-1400. doi: 10.1007/s00392-022-02059-2. Epub 2022 Aug 4.

本文引用的文献

1
Bioprosthetic vs mechanical mitral valve replacement for infective endocarditis in patients aged 50 to 69 years.50 岁至 69 岁患者感染性心内膜炎的生物瓣与机械瓣二尖瓣置换。
Clin Cardiol. 2020 Oct;43(10):1093-1099. doi: 10.1002/clc.23407. Epub 2020 Jun 4.
2
TAVI-in-homograft (TiH): open transcatheter aortic valve replacement in calcified aortic homograft case reports.同种异体移植物中的经导管主动脉瓣置换术（TiH）：钙化主动脉同种异体移植物病例报告中的开放性经导管主动脉瓣置换术
J Cardiothorac Surg. 2019 Nov 27;14(1):208. doi: 10.1186/s13019-019-1036-2.
3
Outcome of a Modified Perceval Implantation Technique.
改良佩尔塞瓦尔植入技术的结果
Thorac Cardiovasc Surg. 2020 Oct;68(7):602-607. doi: 10.1055/s-0039-1685512. Epub 2019 Apr 19.
4
Implantation of Perceval valve in mitral position: A new technique.二尖瓣位Perceval瓣膜植入：一种新技术。
J Thorac Cardiovasc Surg. 2019 Jan;157(1):225-228. doi: 10.1016/j.jtcvs.2018.07.057. Epub 2018 Aug 2.
5
2017 ESC/EACTS Guidelines for the management of valvular heart disease.2017年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2017 Sep 21;38(36):2739-2791. doi: 10.1093/eurheartj/ehx391.
6
Surgery for Infective Endocarditis: Outcomes and Predictors of Mortality in 360 Consecutive Patients.感染性心内膜炎的手术治疗：360 例连续患者的死亡率结果和预测因素。
Med Sci Monit. 2017 Jul 25;23:3617-3626. doi: 10.12659/msm.902340.
7
Valve Selection in End-Stage Renal Disease: Should It Always Be Biological?终末期肾病中的瓣膜选择：是否始终应选择生物瓣膜？
Ann Thorac Surg. 2016 Nov;102(5):1531-1535. doi: 10.1016/j.athoracsur.2016.04.092. Epub 2016 Aug 17.
8
Aortic cross-clamp time, new prostheses, and outcome in aortic valve replacement.主动脉瓣置换术中的主动脉交叉阻断时间、新型人工瓣膜与手术结果
J Heart Valve Dis. 2012 Nov;21(6):732-9.